PLSE Pulse Biosciences, Inc
$52.66▼ -0.68%
Healthcare
Other
Volume 282.5K
Avg Volume (10D) 385.0K
Key Metrics & Fundamentals
Market Cap
$3.76B
P/E Ratio
–
Div Yield
0.00%
52W Range
12.56 - 58.90
% vs 50 MA
4.19%
% vs 200 MA
72.30%
RSI-14
56.6
MACD Histogram
+0.4000
Beta (1Y vs SPY)
2.06
Free Cash Flow
-$18.80M
Gross Rev
$434,000
Gross Profit
$161,000
EBITDA
-$25.02M
COGS
$273,000
Operating Exp
$25.43M
Operating Income
-$25.27M
EBIT
-$25.27M
Pretax Income
-$24.66M
Net Income
-$24.66M
EPS (Diluted)
-0.36
Price & Volume History
Loading chart…
Recent News
Pulse Biosciences (PLSE) Stock Still Seems Rich Against Book Value
Simply Wall St. · Oct 25, 2026 6:08 AM ET
Pulse Biosciences Schedules Third Quarter 2026 Financial Results Conference Call for November 5, 2026
Business Wire · Oct 22, 2026 4:05 PM ET
Pulse Biosciences (PLSE) Stock Fair Value Rises After Analyst Target Increases
Simply Wall St. · Oct 17, 2026 6:11 PM ET
Pulse Biosciences Collaborates With Clayman Thyroid Center on Thyroid Nodule Treatment
MT Newswires · Oct 14, 2026 7:46 AM ET
Pulse Biosciences Announces Commercial and Clinical Partnership with the Clayman Thyroid Center
Business Wire · Oct 14, 2026 7:00 AM ET
Pulse Biosciences' 2027 Trial Readout Crucial to Evaluate New Pulsed Field Ablation Modality, Oppenheimer Says
MT Newswires · Oct 13, 2026 12:40 PM ET
Oppenheimer Adjusts Price Target on Pulse Biosciences to $60 From $35, Keeps Outperform Rating
MT Newswires · Oct 13, 2026 8:56 AM ET
Why Pulse Biosciences (PLSE) Is Up 12.3% After Full NANOPULSE-AF Enrollment And nPulse Spotlight
Simply Wall St. · Oct 10, 2026 5:15 PM ET
Pulse Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Business Wire · Oct 9, 2026 4:05 PM ET
Pulse Biosciences’ nPulse™ Technology to be Featured at the 21st Annual International VT Symposium 2026
Business Wire · Oct 8, 2026 7:00 AM ET
Financial Overview - Income Statement
Quarterly
Jun 2026
See PLSE's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.